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ABSTRACT
Background Most deaths in severely brain-injured
newborns in neonatal intensive care units (NICUs) follow
discussions and explicit decisions to limit life-sustaining
treatment. There is little published information on such
discussions.
Objective To describe the prevalence, nature and
outcome of treatment limitation discussions (TLDs) in
critically ill newborns with severe brain injury.
Design A retrospective statewide cohort study.
Setting Two tertiary NICUs in South Australia.
Patients Ventilated newborns with severe hypoxic
ischaemic encephalopathy and periventricular/
intraventricular haemorrhage (P/IVH) admitted over a
6-year period from 2001 to 2006.
Main outcome measures Short-term outcome (until
hospital discharge) including presence and content of
TLDs, early childhood mortality, school-age functional
outcome.
Results We identiﬁed 145 infants with severe brain
injury; 78/145 (54%) infants had documented TLDs.
Discussions were more common in infants with severe
P/IVH or hypoxic–ischaemic encephalopathy (p<0.01).
Fifty-six infants (39%) died prior to discharge, all
following treatment limitation. The majority of deaths
(41/56; 73%) occurred in physiologically stable infants.
Of 78 infants with at least one documented TLD,
22 (28%) survived to discharge, most in the setting of
explicit or inferred decisions to continue treatment. Half
of long-term survivors after TLD (8/16, 50%) were
severely impaired at follow-up. However, two-thirds of
surviving infants with TLD in the setting of unilateral
P/IVH had mild or no disability.
Conclusions Some critically ill newborn infants with
brain injury survive following TLDs between their parents
and physicians. Outcome in this group of infants
provides valuable information about the integrity of
prognostication in NICU, and should be incorporated
into counselling.
INTRODUCTION
Despite improvements in the care of sick newborns,
some infants admitted to neonatal intensive care
units (NICUs) die. In North America, Australia and
Northern Europe, the majority of deaths in
NICUs follow decisions to limit life-sustaining
treatment.1–5 In these units, it is rare for infants to
die on the ventilator, or while receiving cardiopul-
monary resuscitation (CPR).2 5 Some decisions to
limit treatment are taken for infants who are
physiologically unstable and likely to die soon
regardless of decisions.6 However, up to 50% of
treatment limitation decisions (TLDs) in NICUs
occur in stable infants, on the basis of predicted
poor prognosis and reduced quality of life.2 4 5
The majority of the latter decisions occur in
newborn infants with brain injury.2
Previous studies of TLDs in NICUs have focused
on infants who died.1–5 Yet, anecdotal reports
suggest that some infants who have treatment
limited, nevertheless, survive.7 Moreover, some
parents, when asked about limitation of treatment,
request that support continue.8 9 There is little
information available on how often TLDs occur in
the NICU.10 11 It is unclear how often newborns
survive following TLDs.
The aim of this study was to describe the preva-
lence and nature of TLDs in a cohort of critically
ill newborns with severe brain injury and to assess
the outcomes of these discussions. In addition, we
sought to describe the school-age functional
outcome in survivors. This group of infants may
shed important light on the accuracy of prognosti-
cation for critically ill infants.12
PATIENTS AND METHODS
In South Australia, there are two tertiary NICUs ser-
vicing a population of approximately 1.6 million,
with 18 000 births per year. We searched the neo-
natal databases at both the NICUs to identify
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What is already known on this topic
▸ Most deaths in newborn intensive care follow
decisions by parents and doctors to limit
life-sustaining treatment.
▸ Some newborn infants who die in neonatal
intensive care unit are physiologically stable
and have life-sustaining treatment withdrawn
or withheld because of concerns about future
quality of life.
What this study adds
▸ A high proportion of critically ill newborns with
severe brain injury had documented treatment
limitation discussions between parents and
doctors.
▸ Almost one-third of these newborns ultimately
survived to discharge from hospital.
▸ A majority of infants who had treatment
limitation discussions either died or were
severely disabled; however, some infants
(particularly following intraventricular
haemorrhage) were not impaired.
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newborns admitted between 1 January 2001 and 31 December
2006 with a clinical diagnosis of moderate or severe periventricu-
lar/intraventricular haemorrhage (P/IVH) or hypoxic–ischaemic
encephalopathy (HIE). Moderate-to-severe IVH was deﬁned as a
radiological diagnosis of grade III/IV P/IVH.13
Moderate-to-severe HIE was deﬁned as a clinical diagnosis by the
treating neonatologist of Sarnat stage 2 or 3 encephalopathy.14
We excluded infants who had received <4 h of mechanical
ventilation as TLD were less likely to have occurred. Medical
records were reviewed for all eligible infants by one of the
authors (MB).
TLDs were recorded where there was clear evidence from
medical or nursing notes that palliative care or limitation of
treatment had been discussed with parents. Discussions about
prognosis alone were excluded, as were discussions occurring
outside the NICU.
We recorded options that had been presented to parents. Infants
were classiﬁed according to their physiological stability and need
for respiratory support at the time of discussions (table 1).2 The
conclusions of each discussion (where documented) were
recorded, as well as speciﬁc elements of any treatment limitation.
In-hospital outcome was recorded. Deaths were classiﬁed into four
categories.2
Long-term functional outcome was assessed from the most
recent documented follow-up. Functional outcome and need for
support with activities of daily life were assessed from out-
patient or inpatient encounters, clinic letters and formal devel-
opmental assessments and classiﬁed according to the modiﬁed
Glasgow Outcome Scale (GOS).15 Children with cerebral palsy
were classiﬁed according to the gross motor function classiﬁca-
tion system as assessed by a paediatrician.16
Fisher’s exact test was used to compare the frequency of
TLDs in different diagnostic groups, and the frequency of
outcome between different groups of infants (SAS software, SAS
Institute, Cary, North Carolina, USA). Ethics committee
approval for the study was obtained from both the hospitals.
RESULTS
During the study period, 3153 newborns were admitted to the
two NICUs. We identiﬁed 193 infants with severe brain injury.
Forty-eight were excluded, most on the basis of not requiring
respiratory support (ﬁgure 1). (None of the excluded infants
died prior to discharge. Most had moderate HIE.)
We analysed 145 cases, including 67 infants with HIE and 62
with P/IVH (see online supplementary appendix table 1 for
demographic characteristics). Eight infants had P/IVH combined
with evidence of periventricular leucomalacia (PVL). A further
eight infants had intra-cerebral haemorrhage different from the
typical P/IVH pattern in pre-terms.
TLDs were identiﬁed in 78/145 (54%) infants. Discussions
were more common in infants with stage 3 HIE (compared with
stage 2, p<0.0001), and in infants with grade IV P/IVH (com-
pared with grade III, p<0.01) (table 2). One to six TLDs were
documented per infant (total of 176 discussions (see online sup-
plementary appendix ﬁgure 1)). Forty-seven infants (47/78,
60%) had more than one TLD. In infants with HIE, the ﬁrst
TLD occurred on the day of birth in 14/32 (43%).
The majority of the discussions took place when newborns
were physiologically stable (124/176, 70.5%), while a small pro-
portion were moribund at the time (29/176, 16.4%, ﬁgure 2,
see also the online supplementary appendix ﬁgure 2). In 28
TLDs, the parental decision was to continue intensive care; in
99 TLDs, some form of limitation was documented. In 49
TLDs, it was unclear whether the parents had made a decision;
in all but one case intensive care was continued; this newborn
died at 9 hours following severe HIE and was moribund. In one
case of a critically unstable pre-term infant with grade 2 and 4
P/IVH, a unilateral decision was made by the treating team not
to perform CPR in case of an adverse event; this baby later died
following a TLD with parental agreement.
Mechanical ventilation was the treatment most frequently
withdrawn. Speciﬁc treatments that were to be withheld
included reintubation (16 cases), continuous positive airway
pressure (1), CPR (28) and other therapies (15). In 11 docu-
mented discussions, details of treatment to be limited were not
provided.
In eight cases, some form of limitation involving feeding was
discussed. In one case with HIE, withholding nasogastric tube
(NGT) feeds was agreed; however, this was later revoked on the
parents’ request. In two cases, parents declined withholding of
NGT feeds. For a fourth infant with HIE, it was initially agreed
to only offer oral feeds; this was later changed to NGT feeds at
a reduced volume due to frequent regurgitation. The infant died
on day 18. In a ﬁfth case, parents were offered withdrawing
NGT feeds, agreed, and the infant survived on oral feeds alone
(the infant was unimpaired at age 3). In the one remaining HIE
case, no parental decision was documented: the infant died later
at day 50. In a case with congenital hydrocephalus and IVH,
agreed withholding of NGT feeds was not implemented as the
infant died following extubation. In a case with IVH and PVL,
an NGT was inserted for administration of daily phenobarbit-
one, while feeds were being withheld. In this case subcutaneous
hydration was also withheld. The infant died 10 days after the
documented decision to withhold ﬂuids and feeds.
There was a high observed mortality rate in this cohort. Of
all 145 cases, 56 (39%) infants died before discharge, all follow-
ing one or more TLD. None of the newborns died during CPR.
All newborns died with one or both parents present. One pre-
mature newborn died while connected to the ventilator in his
parents’ arms. In 41 cases, deaths followed withholding/with-
drawing treatment in stable newborns (see online supplementary
appendix table 2).
Table 1 Physiological stability classification
1. Critically unstable/moribund Deteriorating despite high levels of intervention and full organ support. Infants were included in this category if they had protracted
bradycardia or anuria for >24 h, hypotension despite volume infusion and inotropes; persistent desaturation despite mechanical
ventilation and 100% oxygen.
2. Stable, requiring high level of
support
Infants requiring a high level of organ support, but not meeting criteria 1 (above). Infants were included in this category if they were
mechanically ventilated requiring ≥80% oxygen and/or a mean airway pressure of ≥14 cm H2O; had vasopressor-resistant hypotension
requiring infusion of ≥20 mg/kg/min dobutamine/dopamine or requiring adrenaline infusion.
3. Physiologically stable All other infants not fulfilling the above criteria
Criteria were modified from Verhagen et al,2 with addition of an additional category (2) to distinguish decisions likely to be based on quality of life, from decisions that may reflect a
high (but not inevitable) chance of death.
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Most deaths (31/56, 55%) occurred within the ﬁrst week of
life, a further 14/56 (25%) newborns died in the second week of
life. Four infants died outside the NICU, three babies with HIE
stage 3 died at home on day 18, 50 and 70 and one infant with
progressive hydrocephalus and PVL died in the parents’ accom-
modation on hospital premises (day 63 of life). Two infants were
re-admitted to paediatric intensive care unit (PICU) and died fol-
lowing a TLD later. One child died in mid-childhood.
Neurodevelopmental outcome was signiﬁcantly better for
infants without TLDs; most were functionally normal at follow-up
(36/66, 54.5% table 2). Of the 78 infants who had TLDs, 22
(28%) survived to discharge. Eight of 22 (32%) parents had
decided in favour of continued treatment, in 6/22 (27%) no clear
decision was documented, while in 8/22 (32%) parents had agreed
to limitation of treatment (see online supplementary appendix
table 3). Follow-up data were available for 20/22 (ﬁgure 1). Eight
children had severe non-ambulant cerebral palsy (GOS 4), while
eight had mild or no disability (GOS 1 or 2). Four children died in
infancy or early childhood. Outcome was signiﬁcantly worse for
infants with HIE compared with those with P/IVH (table 3). All
the infants who had TLD in the context of severe HIE died or
were severely disabled at follow-up. Four out of seven (57%) new-
borns with unilateral severe P/IVH had normal functional status or
only mild disability at follow-up (the online supplementary appen-
dix table 5 provides details of decisions along with functional
outcome and age of last assessment).
DISCUSSION
In this retrospective study, we identiﬁed a high prevalence of
TLDs in a cohort of critically ill newborn infants with severe
brain injury. All deaths followed decisions to limit or withdraw
treatment. However, about one-quarter of infants whose parents
had held documented TLDs survived. In the majority of these
cases, there was an explicit or inferred decision to continue life-
sustaining treatment. Most infants surviving after TLDs were
severely impaired long term.
Figure 1 Flowchart of cohort,
including outcome at latest follow-up
(GOS, Modiﬁed Glasgow Outcome
Score); N/A—long-term outcome data
not available; TLD—treatment








2—mildly disabled but likely
independent, 3—moderately disabled
and dependent on care, 4—severely
disabled and totally dependent on
care.15
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Treatment limitation—prevalence
Previous studies have found similarly high rates of treatment limi-
tation (69%–94%) among infants dying in NICUs in North
America and Northern Europe,1 2 5 17 though lower rates have
been observed (45%–54%) in Israel18 and South America.19 Prior
studies included a range of underlying pathologies. A variable
proportion of deaths (0%–61%) occurred in stable infants having
treatment withdrawn on the basis of concerns for quality of
life.2 5 17 In our study, focusing on infants with brain injury, about
three-fourths of deaths fell into this ‘stable’ category.
Survival after TLDs
In adult intensive care, a very small proportion of patients
survive after treatment is withdrawn.20–22 A French study in
paediatric intensive care described survival to hospital discharge
in nine out of 30 children who had treatment limitations follow-
ing a family conference.23
Table 2 Diagnosis and outcome in infants with TLD compared
with infants without TLD
TLD No TLD
Diagnosis
HIE—stage 2 2 (5.7%) 33 (94.3%)
HIE—stage 3 30 (93.8%)* 2 (6.2%)*
P/IVH—grade III 5 (27.8%) 13 (72.2%)
P/IVH—grade IV 30 (68.2%)* 14 (31.8%)*
Outcome
Survived 18 (23.1%)† 66 (98.5%)†
GOS 1 4 (22.2%)† 36 (54.5%)†
GOS 2 4 (22.2%) 7 (10.6%)
GOS 3 0 6 (9.1%)
GOS 4 8 (44.4%)† 6 (9.1%)†
N/A 2 (11.1%) 11 (16.7%)
Died‡ 60 (76.9%)† 1 (1.5%)†
For diagnosis, percentages are expressed as a proportion of each category with or
without TLD.
For neurological outcome, percentages are expressed as a proportion of surviving
infants within each outcome category. Survival/Deaths are expressed as a proportion
of all infants with/without TLD.
*p<0.05 (Fisher’s exact test) (comparing frequency of treatment limitation decisions
between infants with stage 3 versus stage 2 HIE, and grade IV versus grade III P/IVH).
†p<0.05 (Fisher’s exact test) (comparing frequency of outcome between infants with/
without TLD).
‡Death includes in-hospital and post-discharge deaths.
GOS, Glasgow Outcome Scale; HIE, hypoxic–ischaemic encephalopathy; P/IVH, peri-/
intraventricular haemorrhage; TLD, treatment limitation discussion.
Figure 2 Severity of illness and treatment limitation discussions (TLD). Each line represents the course of an individual infant. Decisions are
classiﬁed according to the infant’s physiological stability at the time of discussion, while the symbols represent the result of discussions. The shaded
area in the lower ﬁgure indicates infants who were not ventilated (NV) at the time of discussion. (A) Newborns with hypoxic–ischaemic
encephalopathy and other intracranial pathology (‘other intra-cerebral haemorrhage’); (B) newborns with P/IVH (periventricular/intraventricular
haemorrhage) and P/IVH+ periventricular leucomalacia.▲, survived-no parental decision documented; X, died following decision to limit or
withdraw treatment; , limitation/withdrawal -survived; ● survived-parental decision to continue treatment; , unilateral decision; open-ended lines,
patient survived to discharge; □, decision made at referring hospital.










Died in hospital 22 (68.8%) 25 (71.4%) 4 (83.3%) 4 (80%)
Survived to discharge 10 (31.2%) 10 (28.6%) 1 (16.7%) 1 (20%)
GOS 1 1 (10%) 3 (30%) 0 0
GOS 2 0 3 (30%) 0 1 (100%)
GOS 3 0 0 0 0
GOS 4 6 (60%) 1 (10%)*

† 1 (50%) 0
Died in infancy/
childhood
3 (30%) 1 (10%) 1 (50%) 0
N/A 0 2 (20%) 0 0
Neurological outcome and death post-discharge expressed as proportion of infants
surviving to discharge.
*p=0.06 (Fisher’s exact test, comparing severe disability between infants with HIE
and those with P/IVH).
†p<0.01 (Fisher’s exact test, comparing combined outcome of death (post-discharge)
or severe disability between infants with HIE and those with P/IVH).
GOS, Glasgow Outcome Scale; HIE, hypoxic–ischaemic encephalopathy; P/IVH,
periventricular/intraventricular haemorrhage; PVL, periventricular leucomalacia; ICH,
intra-cerebral haemorrhage; TLD, treatment limitation discussion.
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Two previous studies have examined parental treatment deci-
sions and outcome in the NICU. The ﬁrst, published in 1986,
described 75 cases.10 TLDs occurred in about two-thirds; in
four cases, parents requested continuation of intensive care; half
of these babies died on the ventilator. No infant survived after
limitation of treatment.
In a German study, TLDs were studied prospectively in a ter-
tiary neonatal unit.11 Thirty-two infants had an agreed limita-
tion of treatment; of these, three survived to hospital discharge,
two dying at home and one surviving for more than 1 year.
Three out of four infants having decisions to continue treatment
were discharged alive. Neither study reported long-term
outcome in survivors.
Functional outcome after TLDs
In our study, all of the infants with documented TLDs in the
setting of severe HIE were severely disabled with non-ambulant
cerebral palsy at follow-up. This is consistent with earlier studies
that reported 100% rates of severe disability in surviving infants
with Sarnat 3 HIE.24 25 In contrast, in recent cooling trials in
HIE, 36% of infants with severe encephalopathy survived
without severe impairment.26 This lower rate may reﬂect the
early staging of encephalopathy in the cooling trials or possibly
the inﬂuence of cooling itself. Although the cohort described
here preceded the introduction of hypothermia into routine
care for HIE, the majority of surviving infants (6/10) had been
cooled (see online supplementary appendix table 4).
Outcome was more variable in newborn infants with TLDs in
the setting of P/IVH. In previous series, unilateral parenchymal
haemorrhage has been associated with cognitive abilities close
to the general population and mild or no motor problems in a
signiﬁcant proportion of infants.27–29 Newborns with bilateral
parenchymal lesions have been reported to have a high rate of
severe impairment.27 In our study, no newborns with bilateral
grade IV P/IVH survived.
In a study from Chicago, 100% of premature infants with
abnormal ultrasound, whose caregivers believed that death was
likely prior to discharge, either died or were severely
impaired.30 The presence of a TLD might be thought to correl-
ate with physician intuitions of demise. However, in our study,
surviving infants with P/IVH and TLDs had a relatively low rate
of severe impairment.
Absence of end-of-life discussions
There was a small number of infants in this study with particu-
larly severe brain injury but no documentation of TLDs. This
included one infant with bilateral severe IVH and two infants
with Sarnat stage 3 HIE, one of whom survived with signiﬁcant
disability. In the group of infants with unilateral grade IV
P/IVH, one-third of infants did not have documented TLDs.
It was unclear why discussions did not occur in these cases.
One possibility is that neonatologists took into account other
features predicting a better outcome.31 It is possible that vari-
ability in physicians’ propensity to make end-of-life decisions
contributed to a lack of discussion.32 Finally, it is conceivable
that discussions did actually take place, but were not
documented.
Ethical implications
There are a number of potential ethical implications of this
study. Some newborn infants who have life-sustaining treatment
withdrawn or withheld survive to discharge from hospital.7
From our study, and consistent with expectation, this was most
likely to occur in physiologically stable infants having treatment
limited on the basis of quality of life. It is important for clini-
cians to be cautious when predicting demise and to be aware of
the possible need for ongoing palliative care.
Our cohort illustrates some of the challenging questions in
the care of severely brain-injured newborns who are not
dependent on respiratory support. Withdrawal of artiﬁcial nutri-
tion and hydration has been defended as a palliative option in
newborn infants,33–35 yet it has been reported only rarely.36–38
In our study, it was discussed with the parents of eight infants,
including six of the survivors. In two cases, NGT feeds were
withheld, but subsequently reinstated. In another, the infant was
able to maintain enough oral intake to survive long term. The
psychological burden on parents and staff when feeds are with-
held can be substantial.39 40
The long-term outcome of children whose parents have been
offered the option of treatment limitation provides an invalu-
able insight into prognostication and decision making in inten-
sive care.12 Although the outcome for such infants may not be
equivalent to those infants who succumbed, it can identify the
best achievable outcome if treatment is continued, information
important for counselling. Our data support the appropriateness
of decisions to potentially limit life-sustaining treatment in a
cohort of term infants with severe HIE who did not receive
therapeutic hypothermia. The degree of impairment in all sur-
viving infants was sufﬁciently severe that intensive treatment
could be judged, in retrospect, to have been ethically
optional.41 42 However, the much more variable outcome in
infants with P/IVH raises questions about the justiﬁcation of
treatment limitation in this cohort.43 Two-thirds of surviving
infants with unilateral severe P/IVH, whose parents had been
offered treatment limitation, were minimally impaired or unim-
paired at follow-up. Decisions to limit treatment on the basis of
intraventricular haemorrhage need to be taken cautiously,
combine ultrasound variables31 with clinician’s experience30
and include counselling about uncertain prognosis.
Limitations
This was a retrospective study and, as such, some of the ﬁnd-
ings should be treated with caution. Follow-up data were
unavailable for some infants. Severely affected children are
more likely to require tertiary hospital care and may be over-
represented. TLDs are likely to have been richer and more
nuanced than was reﬂected in the medical record and some
discussions may not have been documented or may have been
missed in infants excluded because of lack of respiratory
support. Assessment of outcome for children was limited to
data available from notes, and represents an incomplete picture
of their function and quality of life. Finally, it is possible that
the timing or content of end-of-life discussions or the outcome
for infants have changed since the period of this study.
Therapeutic hypothermia is now standard of care for infants
with HIE, and there have been concerns that this might lead to
delays in TLDs or to increased uncertainty about progno-
sis.44 45 While there was no apparent difference in outcome
between cooled and non-cooled surviving infants in this study,
the numbers are small, and it would be useful to repeat the
study in a larger sample of cooled infants.
CONCLUSION
TLDs occur commonly in the NICU for infants with severe
brain injury. Some newborn infants survive because of parental
decisions to continue treatment, or despite explicit decisions to
withhold life-prolonging treatment. Many, though not all, of
these surviving children have severe life-long disability.
Brecht M, et al. Arch Dis Child Fetal Neonatal Ed 2015;100:F155–F160. doi:10.1136/archdischild-2014-307399 F159
Original article
group.bmj.com on March 22, 2016 - Published by http://fn.bmj.com/Downloaded from 
Prospective studies are needed that combine careful documenta-
tion of the rationale for decisions with long-term follow-up.
There is also a need for research into the long-term care needs
of this highly vulnerable group of children and families.
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